Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$116,028,734
+$12,146,623 QoQ
Shares Held
456,860
+7.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#279
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $567,998,433 across 14 Drug Manufacturers - General names. JNJ ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
118,181 | $141,749,848 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
456,860 | $116,028,734 | |
| 3 | ABBV |
AbbVie Inc.
|
426,678 | $107,369,251 | |
| 4 | PFE |
Pfizer Inc
|
1,884,553 | $45,380,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
323,733 | $41,599,690 | |
| 6 | NVS |
Novartis AG
|
185,906 | $29,135,188 | |
| 7 | AMGN |
Amgen Inc
|
79,199 | $28,679,541 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
229,499 | $13,223,732 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,028,734 | 456,860 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $103,882,111 | 424,980 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $82,886,786 | 400,516 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $66,540,748 | 358,865 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,672,708 | 299,003 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $46,719,781 | 281,716 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $48,359,047 | 334,387 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $56,241,788 | 347,043 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $55,785,179 | 381,672 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $55,667,377 | 351,902 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $51,505,547 | 328,605 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $49,269,955 | 316,340 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $56,715,427 | 342,650 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $48,255,375 | 311,325 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $66,421,989 | 376,009 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $53,395,522 | 326,858 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $55,613,172 | 313,296 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $47,926,713 | 270,421 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $45,545,847 | 266,241 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $47,798,832 | 295,968 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $47,066,382 | 285,701 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $46,001,400 | 279,899 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $52,035,021 | 330,633 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $33,054,933 | 222,024 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||